It's all in your brain
Launching Lutea™ - and how it's different to Nettle™
We’re thrilled to introduce Lutea™ - our newest product, and our first release in the United States. Lutea™ is built on the same scientific foundation as Nettle™, but it represents a new perspective on how we think about women’s brain health, daily wellbeing, and self-care.
We asked Nettle™ users about their experience - here’s what they said
Real women, real results. After six months with Nettle™, users reported fewer sick days, less reliance on medication, and reduced GP visits. 80% said they regained nearly a month of life each year, 9 in 10 changed how they use painkillers or hormones, and over half wish GPs offered Nettle™ first. Proof that menstrual health can mean fewer pills, fewer appointments - and more control.
ENDO-205: the first non-hormonal endometriosis treatment enters clinical trials
The FDA cleared the first non-hormonal drug candidate for endometriosis to enter clinical trials. We explain what ENDO-205 is, why non-hormonal options matter, and what else is in the pipeline for people who can't or won't take hormonal treatments.
PMDD and suicidality: finally the evidence for what millions know to be a lived experience
A major systematic review covering more than 2.6 million people confirms that suicidal thoughts, planning, and attempts are significantly more common in people with PMDD, and that no treatments have yet been studied to address this risk.
Could at-home brain stimulation reduce SSRI reliance?
A new 2026 New York Times feature follows Flow's FDA approval to ask whether at-home brain stimulation could give psychiatry an alternative to SSRIs...here's what it tells us.
New 2026 research on TENS for endometriosis: what the study shows - and doesn't
New 2026 research from Penn State tested at-home TENS - the mechanism behind devices like Livia, Ovira, and Myoovi for endometriosis pain. Quality of life improved and ibuprofen use dropped, but the primary pain outcome didn't move. Here's what that means for people with endometriosis, period cramps, and chronic pelvic pain.
Your brain changes with your cycle: what a 2026 EEG review found
A new 2026 systematic review pulled together 23 resting-state EEG studies across the menstrual cycle. Alpha and theta brain activity shift reliably with hormones - likely reflecting real changes in attention, emotional well-being, and how the brain processes the self. Here's what the evidence actually shows, and what it still can't tell us.
Why your brain reacts differently to progesterone: the ALLO theory of PMDD
After ovulation, your body converts progesterone into a neurosteroid called allopregnanolone (ALLO). For most people, ALLO boosts GABA, the brain's calming signal, and that's that. But researchers at Umeå University in Sweden have found that some women's brains respond to ALLO in the opposite direction, with anxiety and low mood instead of calm.